Combining Daratumumab with VRd Improves Outcomes in Patients with Transplant-Ineligible or Transplant-Deferred Newly Diagnosed Multiple Myeloma By Ogkologos - March 3, 2025 447 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the CEPHEUS study Source RELATED ARTICLESMORE FROM AUTHOR ESMO’s Special Consultative Status with United Nations Economic and Social Council (UN ECOSOC) Confirmed Until 2028 EMA Recommends Extension of Indications for Selumetinib ESMO Calls for Urgent Changes to the in Vitro Diagnostic Medical Devices Regulation (IVDR) in Order to Safeguard Cancer Research in Europe MOST POPULAR Although Not Improving DFS, Adjuvant Avelumab May Potentially Reduce the Risk... September 9, 2025 2020 Cancer Incidence and Mortality in EU-27 Countries July 24, 2020 Cliff Collapse Kills Woman Celebrating Breast Cancer Victory and 2 of... August 5, 2019 Five Questions With…Jessica, Katie, and Melanie July 21, 2022 Load more HOT NEWS ELCC 2015 News: ‘Real-World’ EGFR Mutation Frequency Results From a Large... Making Transformative Advances against Childhood Cancer: A Conversation with Dr. Doug... Holiday Lights Are My Favorite Thing 6-Year-Old Uses Money From Lemonade Stand To Take Mom Out On...
